• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Don't spit into the wind . . .

Article

Still using CT and MR imaging to evaluate head and neck cancers? That's so last millennium. Salivary transcriptome profiling-or spit-is the diagnostic tool for the 21st century.

Still using CT and MR imaging to evaluate head and neck cancers? That's so last millennium. Salivary transcriptome profiling-or spit-is the diagnostic tool for the 21st century.

Using the RNA in saliva, Dr. Li Yang and colleagues at the University of California, Los Angeles differentiated head and neck cancer patients from a group of healthy subjects based on biomarkers found in their spittle. The researchers achieved 91% sensitivity and specificity (Clinical Cancer Research 2004:10;8442-8450).

Although saliva contains the same biomarkers for disease that are found in blood, they are present at much lower levels of magnitude. Nanotechnology now allows scientists to manipulate materials on an atomic or molecular scale, thus revealing the components of saliva.

Researchers hope the techniques will work for other diseases such as breast cancer.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.